208 related articles for article (PubMed ID: 33403252)
1. A Mechanistic Investigation on the Anticancer Properties of SYA013, a Homopiperazine Analogue of Haloperidol with Activity against Triple Negative Breast Cancer Cells.
Asong GM; Amissah F; Voshavar C; Nkembo AT; Ntantie E; Lamango NS; Ablordeppey SY
ACS Omega; 2020 Dec; 5(51):32907-32918. PubMed ID: 33403252
[TBL] [Abstract][Full Text] [Related]
2. An Evaluation of the Anticancer Properties of SYA014, a Homopiperazine-Oxime Analog of Haloperidol in Triple Negative Breast Cancer Cells.
Asong GM; Voshavar C; Amissah F; Bricker B; Lamango NS; Ablordeppey SY
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551533
[TBL] [Abstract][Full Text] [Related]
3. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
4. New analogs of SYA013 as sigma-2 ligands with anticancer activity.
Asong G; Zhu XY; Bricker B; Andey T; Amissah F; Lamango N; Ablordeppey SY
Bioorg Med Chem; 2019 Jun; 27(12):2629-2636. PubMed ID: 30987780
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
[TBL] [Abstract][Full Text] [Related]
6. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
[TBL] [Abstract][Full Text] [Related]
7. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells.
Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
[TBL] [Abstract][Full Text] [Related]
8. Triterpenoid Saponin AG8 from
Mu LH; Wang LH; Yu TF; Wang YN; Yan H; Liu P; Yan C
Oxid Med Cell Longev; 2020; 2020():7963212. PubMed ID: 33123316
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the behavioral and pharmacokinetic profile of SYA013, a homopiperazine analog of haloperidol in rats.
Bricker B; Jackson T; Boateng B; Zhu XY; Ablordeppey SY
Pharmacol Biochem Behav; 2012 Aug; 102(2):294-301. PubMed ID: 22588199
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
Bilir B; Kucuk O; Moreno CS
J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694
[TBL] [Abstract][Full Text] [Related]
11. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
[TBL] [Abstract][Full Text] [Related]
12. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
13. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, and Angiogenesis Inhibition in Triple-Negative Breast Cancer Cells.
Ahmed SA; Mendonca P; Messeha SS; Soliman KFA
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764312
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive proteomics and sialiomics of the anti-proliferative activity of safranal on triple negative MDA-MB-231 breast cancer cell lines.
Zarrineh M; Ashrafian S; Jensen P; Nawrocki A; Ansari AM; Rezadoost H; Ghassempour A; Larsen MR
J Proteomics; 2022 May; 259():104539. PubMed ID: 35240313
[TBL] [Abstract][Full Text] [Related]
16. Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death.
Rowland LK; Campbell PS; Mavingire N; Wooten JV; McLean L; Zylstra D; Thorne G; Daly D; Boyle K; Whang S; Unternaehrer J; Brantley EJ
J Cell Biochem; 2019 Apr; 120(4):6004-6014. PubMed ID: 30450577
[TBL] [Abstract][Full Text] [Related]
17. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET.
Shen Y; Zhang W; Liu J; He J; Cao R; Chen X; Peng X; Xu H; Zhao Q; Zhong J; Ding W; Lei X; Jiang Y; Zu X
Int J Cancer; 2019 Feb; 144(3):651-664. PubMed ID: 30289981
[TBL] [Abstract][Full Text] [Related]
20. Unique cartilage matrix-associated protein inhibits the migratory and invasive potential of triple-negative breast cancer.
Lee SH; Lee YJ; Park SI; Kim JE
Biochem Biophys Res Commun; 2020 Oct; 530(4):680-685. PubMed ID: 32768190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
